NASDAQ:MIRO Miromatrix Medical (MIRO) Stock Price, News & Analysis → Like Investing in Big Tech in the Early 2000s? (From Manward Press) (Ad) Free MIRO Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$3.39▼$3.3950-Day Range$3.31▼$3.4052-Week Range$0.91▼$4.35VolumeN/AAverage Volume80,095 shsMarket Capitalization$92.95 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisEarningsHeadlinesInsider TradesOwnershipTrendsStock AnalysisEarningsHeadlinesInsider TradesOwnershipTrends Get Miromatrix Medical alerts: Email Address Ad The Freeport SocietyThe last Republican president?History shows Donald Trump is poised to go down as the last Republican President for a generation or more. How is this possible, with Biden so unpopular, and Trump running at least neck-in-neck with him in polls?This presentation explains exactly why. About Miromatrix Medical Stock (NASDAQ:MIRO)Miromatrix Medical Inc., a life sciences company, develops a novel technology for bioengineering fully transplantable organs. The company's proprietary technology is a platform that uses a two-step method of decellularization and recellularization designed to remove the porcine cells from the organs obtained from pigs and replace them with unmodified human cells. It has collaborations with Baxter, CareDx, The Mayo Clinic, Mount Sinai Hospital, and The Texas Heart Institute. The company was formerly known as TayTech, Inc. Miromatrix Medical Inc. was incorporated in 2009 and is headquartered in Eden Prairie, Minnesota.Read More Ad The Freeport SocietyThe last Republican president?History shows Donald Trump is poised to go down as the last Republican President for a generation or more. How is this possible, with Biden so unpopular, and Trump running at least neck-in-neck with him in polls?This presentation explains exactly why. MIRO Stock News HeadlinesFebruary 22, 2024 | uk.finance.yahoo.comQ4 2023 United Therapeutics Corp Earnings CallNovember 22, 2023 | benzinga.comBest Stocks to Buy Right NowNovember 15, 2023 | msn.comMiromatrix Medical GAAP EPS of -$0.24, revenue of $11.17MNovember 14, 2023 | finance.yahoo.comMiromatrix Reports Third Quarter 2023 ResultsOctober 31, 2023 | proactiveinvestors.comMiromatrix Medical climbs 225% following $140m United Therapeutics bidOctober 31, 2023 | msn.comUnited Therapeutics agrees to buy Miromatrix MedicalOctober 31, 2023 | marketwatch.comMiromatrix Medical Shares Triple After United Therapeutics OfferOctober 30, 2023 | startribune.comEden Prairie biotech company Miromatrix Medical sells for $91MOctober 30, 2023 | msn.comUnited Therapeutics to buy Miromatrix Medical for $3.25 per shareOctober 30, 2023 | investorplace.comWhy Is Miromatrix Medical (MIRO) Stock Up 235% Today?October 11, 2023 | finance.yahoo.comMiromatrix to Present at the 2023 ISODP Organ Donation CongressOctober 5, 2023 | finance.yahoo.comMiromatrix CEO Jeff Ross to Present at the 2023 Cell & Gene Meeting on the MesaSeptember 10, 2023 | finance.yahoo.comSeveral Insiders Invested In Miromatrix Medical Flagging Positive NewsSeptember 5, 2023 | finance.yahoo.comMiromatrix Announces Participation in the ARM Tissue Engineering and Therapeutics WorkshopAugust 21, 2023 | finance.yahoo.comMiromatrix Medical Inc. (NASDAQ:MIRO) Q2 2023 Earnings Call TranscriptAugust 15, 2023 | finanznachrichten.deMiromatrix Medical Inc.: Miromatrix Reports Second Quarter 2023 Results and Provides Corporate UpdateAugust 15, 2023 | msn.comMiromatrix Medical GAAP EPS of -$0.24August 15, 2023 | markets.businessinsider.comCraig-Hallum Keeps Their Buy Rating on Miromatrix Medical (MIRO)August 15, 2023 | finance.yahoo.comQ2 2023 Miromatrix Medical Inc Earnings CallAugust 14, 2023 | msn.comMiromatrix Medical GAAP EPS of -$0.24 beats by $0.05, revenue of $8.52M beats by $8.52MAugust 14, 2023 | finance.yahoo.comMiromatrix Reports Second Quarter 2023 Results and Provides Corporate UpdateAugust 11, 2023 | benzinga.comPreview: Miromatrix Medical's EarningsAugust 10, 2023 | msn.comLab-grown ‘ghost hearts' work to solve organ transplant shortage by combining a cleaned-out pig heart with a patient’s own stem cellsJuly 25, 2023 | finance.yahoo.comMiromatrix to Report Second Quarter 2023 Financial ResultsJuly 13, 2023 | finance.yahoo.comMiromatrix Poster Voted Best in Congress at the 2023 American Transplant Congress; Jack Lake Wins Lifetime Achievement AwardSee More Headlines Receive MIRO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Miromatrix Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/15/2021Today6/13/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolNASDAQ:MIRO CUSIPN/A CIK1527096 Webwww.miromatrix.com Phone952-942-6000FaxN/AEmployees76Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($1.14) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-29,960,000.00 Net Margins-2,861.17% Pretax Margin-2,861.17% Return on Equity-120.49% Return on Assets-90.70% Debt Debt-to-Equity Ratio0.02 Current Ratio3.46 Quick Ratio3.46 Sales & Book Value Annual Sales$958,029.00 Price / Sales97.02 Cash FlowN/A Price / Cash FlowN/A Book Value$1.25 per share Price / Book2.71Miscellaneous Outstanding Shares27,419,000Free Float25,993,000Market Cap$92.95 million OptionableOptionable Beta0.01 (Almost) Everything You Need To Know About The EV MarketClick the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise. Get This Free Report Key ExecutivesDr. Jeffrey James Ross Ph.D. (Age 47)CEO & Director Comp: $797.5kMr. James M. Douglas (Age 49)CFO & Secretary Comp: $487.5kMr. Rodrigo Mesquita P.M.P.Vice President of Manufacturing & OperationsMr. Tom EmigVice President of People & CultureKey CompetitorsNeon TherapeuticsNASDAQ:NTGNEntasis TherapeuticsNASDAQ:ETTXLianBioNASDAQ:LIANPHAXIAM TherapeuticsNASDAQ:PHXMPolarityTENASDAQ:PTEIQView All Competitors MIRO Stock Analysis - Frequently Asked Questions How were Miromatrix Medical's earnings last quarter? Miromatrix Medical Inc. (NASDAQ:MIRO) released its earnings results on Monday, November, 15th. The company reported ($0.25) EPS for the quarter, missing analysts' consensus estimates of ($0.13) by $0.12. The firm had revenue of $0.01 million for the quarter. Miromatrix Medical had a negative trailing twelve-month return on equity of 120.49% and a negative net margin of 2,861.17%. When did Miromatrix Medical IPO? Miromatrix Medical (MIRO) raised $32 million in an IPO on Thursday, June 24th 2021. The company issued 4,000,000 shares at a price of $7.00-$9.00 per share. Craig-Hallum Capital Group served as the underwriter for the IPO. This page (NASDAQ:MIRO) was last updated on 6/13/2024 by MarketBeat.com Staff From Our PartnersAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredLike Investing in Big Tech in the Early 2000s?More than a decade after the first Bitcoin was mined, people are finally realizing something very important......Manward Press | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredEstee Lauder, MAC, and other beauty brands are raving about this emerging NYSE AI companyA Little-known NYSE Company is Empowering the Beauty Industry with Innovative AI and AR Tools.Financial Markets Daily | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredA once-in-a-century investment opportunityIt's an under-the-radar stock reshaping a projected $109 billion industry - And, I believe, has far more poten...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Miromatrix Medical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Miromatrix Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.